Virtual Library
Start Your Search
E. Szabo
Author of
-
+
P1.07 - Poster Session with Presenters Present (ID 459)
- Event: WCLC 2016
- Type: Poster Presenters Present
- Track: SCLC/Neuroendocrine Tumors
- Presentations: 1
- Moderators:
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.07-055 - Introducing the US National Cancer Institute’s Small Cell Lung Cancer Consortium (ID 6065)
14:30 - 14:30 | Author(s): E. Szabo
- Abstract
Background:
Small cell lung cancer (SCLC) remains a major clinical challenge, however recent discoveries and early positive signals in clinical trials are promising more optimistic outcomes for patients with this disease. The United States National Cancer Institute (NCI) launched in December 2015 a series of solicitations for grant applications with the goal to establish a SCLC consortium. The Consortium will address five strategic priority areas established by an international group of experts and the NCI. These areas are: 1. Better research tools for the Study of SCLC, 2. Comprehensive genomic profiling of SCLC, 3. New diagnostic and prevention approaches for SCLC, 4. Therapeutic development efforts, and 5. Mechanisms underlying both high rate of initial response and rapid emergence of drug and radiation resistance. The initiative for early detection and prevention of SCLC is now open for potential applicants through 2017 (PAR-16-51); applications for therapy and mechanism of resistance projects can be submitted through 2018 (PAR-16-49).
Methods:
Section not applicable
Results:
(Note: The first round of application was reviewed right before the IASLC abstract submission deadline, funding decisions will be made in early November 2016, so by the time of the November 11 deadline for the poster submission we will be able to include the first funded projects in the consortium in the abstract and in the poster.)
Conclusion:
Section not applicable
